ENS Stock Cash Flow Statements

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Net Income

Quarterly

Annual

Quarterly Cash Flow Statements

Quarterly

Annual

Unit: USD	2023-12-31	2023-10-01	2023-07-02	2023-03-31	2023-01-01	2022-10-02	2022-07-03	2022-03-31	2022-01-02	2021-10-03	2021-07-04	2021-03-31	2021-01-03	2020-10-04	2020-07-05	2020-03-31	2019-12-29	2019-09-29	2019-06-30	2019-03-31	2018-12-30	2018-09-30	2018-07-01	2017-12-31	2017-03-31	2016-07-03	2015-09-27	2015-06-28	2014-12-28	2014-03-31	2013-06-30	2012-09-30	2012-07-01	2012-03-31	2012-01-01	2011-10-02	2011-07-03	2011-03-31	2011-01-02	2010-10-03	2010-07-04

cash flows from operating activities
net earnings	76,158,000	65,229,000	66,797,000	65,950,000	44,410,000	34,472,000	30,978,000	28,092,000	36,264,000	35,626,000	43,929,000	33,836,000	38,624,000	35,731,000	35,183,000	-1,523,000	27,305,000	62,698,000	48,636,000	18,546,000	48,614,000	47,447,000	46,020,000	-25,779,000	33,716,000	44,619,000	39,768,000	47,934,000	49,331,000	12,809,000	40,417,000	43,011,000	45,564,000	45,323,000	36,859,000	28,289,000	33,496,000	30,091,000	33,759,000	26,549,000	23,027,000
adjustments to reconcile net earnings to net cash from operating activities:
depreciation and amortization	23,090,000	22,521,000	22,693,000	22,155,000	22,593,000	22,781,000	23,624,000	23,556,000	23,982,000	23,907,000	24,433,000	23,890,000	23,133,000	23,402,000	23,657,000	21,556,000	24,735,000	20,328,000	20,725,000	20,837,000	15,209,000	13,606,000	13,696,000	13,696,000	13,477,000	13,768,000	14,236,000	13,615,000	13,758,000	15,069,000	12,607,000	12,620,000	12,450,000	13,338,000	12,769,000	12,131,000	12,122,000	11,172,000	10,776,000	11,269,000	11,176,000
write-off of assets relating to exit activities	17,360,000	803,000	3,343,000		-721,000	1,636,000	7,445,000		166,000	1,615,000	2,141,000		5,539,000	1,282,000	471,000				802,000		3,425,000	0	1,073,000
impairment of indefinite-lived intangibles
derivatives not designated in hedging relationships:
net incomees	-538,000										6,000					-339,000	-179,000			1,466,000	-232,000	-96,000	718,000		269,000	302,000	285,000	9,000		132,000	226,000	381,000	129,000	-1,034,000	-252,000
cash (settlements) proceeds	-898,000	38,000	657,000		2,055,000	-1,415,000	-600,000				-14,000															-352,000
benefit from doubtful accounts	456,000	952,000	504,000	289,000	-926,000	379,000	-173,000	688,000	693,000	201,000	1,039,000	-92,000	88,000	86,000	96,000	1,899,000	-323,000	2,140,000	1,105,000	536,000	717,000	-122,000	254,000	11,000	-158,000	921,000	1,873,000	496,000	42,000	629,000	-217,000	11,000	-131,000	73,000	-429,000	1,153,000	598,000	-351,000	1,345,000	371,000	148,000
deferred income taxes	-304,000	4,000	42,000	-14,520,000	-590,000	-146,000	20,000	1,139,000	-132,000	-37,000	145,000	-7,209,000	35,000	-1,766,000	-54,000	4,462,000	25,000	-21,010,000	37,000	-6,234,000	-1,049,000	1,022,000	-195,000	-6,783,000	2,138,000	-204,000	1,034,000	-4,352,000	-319,000	-24,806,000	153,000	-195,000	-707,000	-3,400,000	131,000	-4,000	46,000
non-cash interest expense	409,000	410,000	410,000	503,000	487,000	487,000	487,000	487,000	487,000	615,000	518,000	518,000	518,000	518,000	518,000	513,000	408,000	374,000	378,000	363,000	326,000	314,000	313,000	314,000	347,000	347,000	341,000	1,763,000	2,423,000	2,232,000	2,235,000	2,171,000	2,139,000	2,003,000	2,190,000	1,912,000	1,878,000	1,926,000	1,895,000	2,095,000	1,860,000
stock-based compensation	9,817,000	5,144,000	7,933,000	7,601,000	6,906,000	6,534,000	5,330,000	8,472,000	6,393,000	5,765,000	3,659,000	2,835,000	6,396,000	5,533,000	5,053,000	6,021,000	5,891,000	4,994,000	3,874,000	8,021,000	5,458,000	4,788,000	4,341,000	5,250,000	4,629,000	5,067,000	6,099,000	4,239,000	4,280,000	4,556,000	3,023,000	3,825,000	3,373,000	2,821,000	3,030,000	3,016,000	2,718,000	2,362,000	2,358,000	2,226,000	2,110,000
(gain) loss on disposal of property, plant, and equipment	486,000	115,000	43,000		-58,000	-95,000	-40,000													-101,000			-5,000										-108,000		9,000
changes in assets and liabilities:
accounts receivable	46,140,000	20,170,000	73,198,000	-55,845,000	141,807,000	-23,947,000	5,538,000	-88,692,000	-56,178,000	-8,920,000	24,834,000	-62,364,000	-35,504,000	13,829,000	92,752,000	-32,293,000	32,016,000	24,666,000	2,097,000	-15,886,000	23,416,000	-4,840,000	3,284,000	10,575,000	-36,378,000	29,038,000	19,453,000	21,446,000	40,985,000	-23,586,000	-21,395,000	11,308,000	-22,841,000	443,000	31,613,000	-25,933,000	983,000	-26,192,000	-6,766,000	-47,841,000	18,907,000
inventories	16,872,000	21,494,000	-10,965,000	39,492,000	2,422,000	-56,873,000	-81,454,000	-49,092,000	-38,268,000	-79,172,000	-46,307,000	-3,893,000	6,989,000	6,228,000	14,852,000	15,509,000	-13,201,000	7,250,000	-18,937,000	-10,174,000	-14,749,000	-1,346,000	-20,345,000	6,700,000		-22,116,000	1,120,000	-5,919,000	-11,746,000
prepaid and other current assets	10,289,000	-9,802,000	-4,089,000	32,012,000	9,221,000	-12,079,000	-5,465,000	-13,700,000	625,000	-3,374,000	-15,595,000	12,245,000	7,678,000	4,697,000	2,672,000	-10,531,000	11,237,000	-11,181,000	-7,033,000	-7,688,000	-8,269,000	-4,726,000	488,000	4,144,000	15,266,000	-2,889,000	1,191,000	2,147,000	-1,947,000	8,051,000					5,362,000	-8,277,000	-2,667,000		-112,000	3,223,000	-9,342,000
other assets	-37,000	-822,000	-484,000	-5,399,000	-633,000	620,000	-886,000	-1,052,000	-364,000	1,342,000	344,000	-2,588,000	-120,000	2,414,000	718,000	-597,000	-1,013,000	2,858,000	1,841,000	-6,351,000	109,000	-1,035,000	-334,000	-372,000	1,177,000	510,000	-844,000	-351,000	-1,331,000	-1,442,000	156,000	3,252,000	-1,394,000	-1,105,000	-817,000	-234,000	1,201,000	-149,000	-1,282,000	-601,000	-520,000
accounts payable	11,583,000	-17,926,000	-39,307,000	27,378,000	-10,197,000	11,656,000	-33,073,000	74,402,000	23,608,000	4,052,000	-36,746,000	61,730,000	8,624,000	-8,948,000	-40,609,000	11,395,000	-22,880,000	-15,208,000	-6,797,000	10,593,000	-1,513,000	10,441,000	-9,577,000	-12,531,000	15,546,000	-4,431,000	-12,926,000	15,503,000	-18,208,000	11,369,000	-6,020,000	-3,057,000	-12,471,000	-4,140,000	1,685,000	1,099,000	-11,021,000	26,958,000	10,508,000	20,120,000	-15,164,000
accrued expenses	-82,054,000	1,844,000	-46,647,000	22,896,000	-7,706,000	15,530,000	-24,973,000	19,655,000	-10,220,000	2,301,000	-50,314,000	22,518,000	8,557,000	19,853,000	-18,571,000	14,350,000	11,281,000	-2,301,000	-16,275,000	-19,243,000	34,930,000	-7,148,000	-13,476,000	1,881,000	-4,523,000	-5,286,000	16,361,000	-7,719,000	2,362,000	79,121,000	-7,896,000	6,062,000	-8,619,000	9,053,000	10,633,000	520,000	-6,701,000	5,706,000	-4,844,000	7,840,000	-12,524,000
other liabilities	-325,000	-98,000	315,000	-168,000	-1,071,000	1,362,000	1,567,000	1,229,000	1,085,000	-1,346,000	-219,000	1,510,000	-11,292,000	-2,502,000	-452,000	2,088,000	-4,816,000	-10,242,000	320,000	8,615,000	-23,815,000	284,000	20,000	87,302,000	556,000	1,304,000	4,264,000	-2,415,000	2,147,000	1,950,000	-194,000	-6,006,000	4,610,000	4,134,000	-7,725,000	2,333,000	45,000	6,796,000	-1,473,000	4,421,000	59,000
net cash from operating activities	134,524,000	110,777,000	74,946,000	144,095,000	206,144,000	1,590,000	-71,891,000	12,445,000	-12,459,000	-17,428,000	-48,143,000	86,276,000	54,826,000	100,709,000	116,564,000	77,566,000	70,770,000	74,678,000	30,384,000	31,431,000	82,392,000	58,456,000	25,576,000	84,445,000	79,323,000	67,557,000	92,290,000	82,330,000	82,348,000	94,571,000	34,392,000	54,555,000	24,215,000	84,210,000	92,764,000	10,220,000	17,002,000	31,547,000	37,839,000	19,810,000	-12,737,000
cash flows from investing activities
capital expenditures	-23,151,000	-19,761,000	-16,093,000	-31,260,000	-17,859,000	-16,639,000	-23,014,000	-21,690,000	-17,729,000	-18,187,000	-16,435,000	-16,278,000	-13,837,000	-13,575,000	-26,330,000	-40,489,000	-17,558,000	-26,063,000	-17,315,000	-17,700,000	-17,172,000	-19,961,000	-15,539,000	-16,447,000	-14,064,000	-7,487,000	-13,849,000	-19,670,000	-19,671,000	-13,139,000	-12,828,000	-10,614,000	-16,060,000	-13,911,000	-10,879,000	-12,479,000	-11,674,000	-18,738,000	-16,950,000	-13,381,000	-10,871,000
purchase of business	0	0	-8,270,000
proceeds from termination of net investment hedges				0	0
proceeds from disposal of property, plant, and equipment	30,000	1,963,000	44,000	134,000	76,000	237,000	139,000	107,000	1,300,000	84,000	49,000	31,000	64,000	31,000	50,000	-687,000	73,000	2,601,000	44,000	554,000	360,000	177,000	12,000	153,000		82,000	711,000	69,000	74,000	145,000	1,128,000	75,000	14,000	-18,000	23,000	27,000	44,000	119,000	307,000	53,000	0
net cash from investing activities	-23,121,000					26,982,000	-22,875,000	-21,583,000	-16,429,000	-18,103,000	-13,118,000	-16,247,000	-8,973,000	-13,544,000	-26,280,000	-40,456,000	-193,630,000	-23,462,000	-17,271,000	-21,760,000	-666,812,000	-19,784,000	-15,527,000	-16,294,000	-14,001,000	-19,797,000	-51,274,000	-11,365,000	-19,597,000	-38,326,000	-11,700,000	-10,539,000	-16,046,000	-17,436,000	-30,792,000	-13,562,000	-11,630,000	-49,422,000	-16,545,000	-13,628,000	-12,066,000
cash flows from financing activities
net (repayments) borrowings on short-term debt	-379,000	343,000	-404,000		-3,250,000	-9,045,000	-8,022,000												-19,499,000
proceeds from second amended revolver borrowings	10,000,000	92,500,000	80,000,000		47,000,000	80,900,000	163,200,000		149,100,000
repayments of second amended revolver borrowings	-75,000,000	-36,120,000	-216,380,000		-237,982,000	-156,900,000	-27,200,000		-34,100,000
repayments of second and third amended term loans	-6,380,000
financing costs for debt modification					0
option proceeds	0	2,014,000	7,654,000	3,332,000	946,000			63,000	115,000	772,000	386,000	4,296,000	3,052,000	1,287,000	479,000	912,000	480,000	-13,000	38,000	4,000	780,000	1,467,000	6,797,000	107,000		5,000
payment of taxes related to net share settlement of equity awards	-2,144,000			-68,000	-128,000	-5,624,000	-633,000	-30,000	-120,000	-4,197,000	-4,803,000	-194,000	-357,000	-1,467,000	-3,135,000	-112,000	-31,000	-169,000	-6,081,000	-246,000	0	69,000	-3,453,000	-70,000	221,000	-7,644,000
purchase of treasury stock	-34,991,000			0	0	0	-22,907,000	-41,832,000	-83,022,000	0	-31,512,000					0	0	-11,532,000	-23,029,000	-31,436,000				0			-120,000,000	-637,000	-55,090,000	-20,299,000	-21,993,000
dividends paid to stockholders	-9,082,000	-9,168,000	-7,173,000	-7,151,000	-7,140,000	-7,138,000	-7,108,000	-7,166,000	-7,296,000	-7,456,000	-7,435,000	-7,474,000	-7,459,000	-7,451,000	-7,428,000	-7,406,000	-7,401,000	-7,399,000	-7,499,000	-7,463,000	-7,533,000	-7,376,000	-7,371,000	-7,372,000	-7,600,000	-7,600,000	-7,768,000	-7,785,000	-7,865,000	-5,872,000	-5,965,000
other	220,000	336,000	354,000		274,000	361,000	207,000		214,000	179,000	214,000		211,000	244,000	11,000		425,000	188,000	-27,000		-1,000	-24,000	54,000			-29,000	-191,000	146,000
net cash (used in) financing activities	-117,756,000
effect of exchange rate changes on cash and cash equivalents	11,316,000	-6,051,000	-3,001,000	3,269,000	17,202,000	-18,964,000	-22,016,000	-7,525,000	-3,997,000	-6,185,000	4,771,000	-10,722,000	15,341,000	9,025,000	6,578,000	-11,889,000	5,902,000	-9,038,000	1,530,000	-2,979,000	-8,011,000	-4,281,000	-28,184,000	6,313,000	6,799,000	-7,991,000	-4,522,000	5,580,000	-9,657,000	79,000	-125,000	3,216,000	-6,406,000		-126,000	-4,090,000	1,652,000		-1,336,000	5,447,000	-3,002,000
net decrease in cash and cash equivalents	4,963,000	69,409,000	-88,323,000		3,658,000	-88,820,000	-19,245,000
cash and cash equivalents at beginning of period	0	0	346,665,000		0	0	402,488,000		0	0	451,808,000		0	0	326,979,000		0	0	299,212,000		0	0	522,118,000	0		397,307,000	0	268,921,000	0		249,348,000	0	160,490,000		0	0	108,869,000		0	0	201,042,000
cash and cash equivalents at end of period	4,963,000	69,409,000	258,342,000		3,658,000	-88,820,000	383,243,000		-10,446,000	1,273,000	406,233,000		74,419,000	29,853,000	384,379,000		-152,336,000	162,733,000	262,113,000		-148,025,000	32,720,000	512,463,000	31,209,000		413,559,000	-124,214,000	444,779,000	40,083,000		240,058,000	31,631,000	180,711,000		24,173,000	-20,983,000	116,577,000		32,766,000	-786,000	173,814,000
net gains			503,000		-1,855,000	688,000	-216,000		-304,000						-262,000
net cash (used in) investing activities			-24,319,000
net cash from financing activities			-135,949,000	-67,654,000	-201,905,000	-98,428,000	97,537,000	22,091,000	22,439,000	42,989,000	10,915,000	-96,150,000	13,225,000			29,248,000	-35,378,000	120,555,000	-51,742,000	-104,638,000	444,406,000	-1,671,000	8,480,000	-43,255,000		-23,517,000	-160,708,000	99,313,000	-13,011,000	-27,862,000	-31,857,000	-15,601,000	18,458,000	-27,842,000	-37,673,000	-13,551,000	684,000	-83,647,000	12,808,000	-12,415,000	577,000
loss on assets held for sale
cash proceeds								-87,000	195,000				-56,000														494,000	307,000	263,000
gain on disposal of property, plant, and equipment								38,000			4,000	124,000	-4,163,000	83,000	73,000		7,000	-140,000	21,000					77,000		-59,000	12,000	-25,000	-21,000		-328,000
changes in assets and liabilities, net of effects of acquisitions:
proceeds from disposal of facility								0	0	0	3,268,000
insurance proceeds relating to property, plant and equipment												0				0
net borrowings (repayments) on short-term debt										-3,357,000	5,512,000
proceeds from second amended 2017 revolver borrowings
repayments of second amended 2017 revolver borrowings
repayments of 2023 senior notes
repayments of second amended 2017 term loan
debt issuance costs								0	0							0				-158,000				0
finance lease obligations and other
net increase in cash and cash equivalents								5,428,000	-10,446,000	1,273,000	-45,575,000	-36,843,000	74,419,000	29,853,000	57,400,000			162,733,000	-37,099,000	-97,946,000	-148,025,000	32,720,000	-9,655,000	31,209,000	33,180,000	16,252,000	-124,214,000	175,858,000	40,083,000	28,462,000	-9,290,000	31,631,000	20,221,000	40,723,000			7,708,000	-96,925,000	32,766,000	-786,000	-27,228,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
repayments of second amended term loan									0
impairment of goodwill
proceeds from 2017 revolver borrowings											65,700,000		45,000,000	10,000,000	35,000,000		41,700,000	190,000,000	95,000,000			20,500,000	64,000,000	13,300,000
repayments of 2017 revolver borrowings											-5,700,000		-23,000,000	-45,000,000	-55,000,000		-362,700,000	-50,000,000	-85,000,000			-10,500,000	-54,500,000	-53,200,000
repayments of 2017 term loan											-11,447,000		-11,357,000	-8,435,000	-8,402,000		-5,631,000	0	-5,645,000
impairment of indefinite-lived intangibles and fixed assets
net (gains) losses												162,000	-220,000						-34,000					-93,000					232,000
legal proceedings accrual
repayments of amended 2017 term loan
supplemental disclosures:
non-cash investing and financing activities:
repayments of 2017 amended term loan
net (payments) borrowings on short-term debt
net payments on short-term debt
gain on disposition of equity interest in altergy
impairment of goodwill, indefinite-lived intangibles and fixed assets
legal proceedings accrual / (reversal of legal accrual, net of fees) - see note 18
(gain) loss on disposal of fixed assets
proceeds from disposal of property, plant, and equipment and other assets
proceeds from the issuance of common stock
prepayment of accelerated stock repurchase
non-cash restructuring charges
(gain) on disposition of equity interest in altergy/ write - off of investment in altergy
reversal of legal accrual, net of fees - see note 18
purchase of businesses, net of cash acquired
deferred financing fees
option proceeds (taxes paid related to net share settlement of equity awards)																													8,000	74,000
payment of deferred purchase consideration
reversal of legal accrual, net of fees - see note 7
gain on disposition of equity interest in altergy - see note 7
taxes paid related to net share settlement of equity awards, net of option proceeds																											6,000	-15,291,000			-7,952,000
goodwill impairment charges
purchases of businesses
payment of deferred consideration
write-off of assets related to restructuring
proceeds from long-term debt—other
payments of long-term debt—other
deferred financing fees incurred in connection with refinancing prior credit facility
proceeds from noncontrolling interests
non-cash write-off of assets relating to restructuring
payments of long-term debt - other
write-off of assets related to restructuring activities
write-off of deferred financing fees
bargain purchase gain
effect of exchange rate changes on cash
borrowings from revolving credit facility
repurchase of common stock of 58,383, net of payable to broker of 8,495 - see note 13
gain on sale of facilities
(gain)/loss on disposal and impairment of fixed assets
proceeds from the issuance of long-term debt
exercise of stock options
tax benefits from exercise of stock options
write-off of deferred finance fees
benefit from deferred taxes
stock compensation expense
increase (reduction) in deferred taxes
accretion of non-cash interest expense
acquisitions, net of cash received
payments of capital lease obligations
gain on sale of manufacturing facility
gain on disposal and impairment of fixed assets
reduction in deferred taxes
loss on disposal and impairment of fixed assets
net increase increase in cash and cash equivalents
(gain) loss on disposal and impairment of fixed assets
changes in assets and liabilities, net of effects of acquisition:
benefit from deferred taxes, less amounts related to restructuring
benefit from (reduction in) deferred taxes
write-off of deferred financing costs
net proceeds from initial public offering